FORMULATION FOR MENOPAUSAL WOMEN
The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from systems associated with menopause, as well as prophylactic effects, and methods for using same.
1 . A composition for supplementing the diet, the composition comprising:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and
b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.
2 . A composition for administration to premenopausal and menopausal women, the composition comprising:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and
b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.
3 . A method for providing nutritional supplementation to a menopausal woman, which comprises:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and
b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.
4 . A method for providing nutritional supplementation to a premenopausal woman, which comprises:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and
b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.